Country: Germany
Language: English
Source: HMA (Heads of Medicines Agencies)
pyrantel pamoate 439 mg
Caballo B.V.
QP52C
Oral paste
AGENTS AGAINST NEMATODOSIS
Horses Food
2010-02-07
1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Hippotwin 439 mg/g oral paste for horses. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION COMPOSITION PER GRAM ACTIVE SUBSTANCE: Pyrantel embonate (equivalent to 152.2 mg of pyrantel) 439 mg EXCIPIENT(S): Methyl parahydroxybenzoate(E 218) 1 mg Propyl parahydroxybenzoate (E 216). 0.3 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral paste Yellow, viscous, oily paste 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses, ponies and foals (of over 8 weeks of age). 4.2 INDICATIONS FOR USE,SPECIFYING THE TARGET SPECIES Infestations with adult stages of roundworm, particularly ascarids (_Parascaris equorum_), small strongyles (_Cyathostomum spp., Triodontophorus spp_.) and large strongyles (_Strongylus edentatus, _ _Strongylus equinus, Strongylus vulgaris_), seatworm/pinworm (_Oxyuris equi_) and tapeworm (_Anoplocephala perfoliata_) in horses, ponies and foals. The efficacy towards _Anoplocephala perfoliata_ is variable. 4.3 CONTRAINDICATIONS Do not use in animals known to be hypersensitive to the active substance. 4.4 SPECIAL WARNINGS Treatment against tapeworms should only be undertaken when tapeworms have been diagnosed. Resistance to pyrantel embonate has been reported in cyathostomins in horses. Therefore the use of this product should be based on local (regional, farm) epidemiological information about susceptibility of cyathostomins and recommendations on how to limit further selection for resistance to anthelmintics. Care should be tak Read the complete document